Yuvicyp-T Syrup is a combination pharmaceutical formulation containing Cyproheptadine 2mg and Tricholine Citrate 275mg per dose, designed to provide therapeutic benefits in conditions requiring antihistaminic and hepatoprotective actions. Cyproheptadine, a potent first-generation antihistamine with antiserotonergic properties, is effective in the management of allergic conditions such as rhinitis, urticaria, and pruritus by blocking histamine H1 receptors and serotonin receptors, thereby reducing allergic symptoms and improving patient comfort. Tricholine Citrate serves as a hepatoprotective agent, promoting liver function by enhancing lipid metabolism and facilitating the removal of hepatic toxins, making it beneficial in cases of liver disorders and associated metabolic dysfunctions. The synergistic combination in Yuvicyp-T Syrup aids in alleviating allergic manifestations while supporting liver health, particularly in patients with concomitant hepatic impairment or those requiring improved metabolic clearance. This formulation is indicated for use under medical supervision, with dosage tailored according to the severity of symptoms and patient response. Caution is advised in patients with known hypersensitivity to either component, and it should be used judiciously in populations such as children, pregnant or lactating women. Adverse effects may include drowsiness, dry mouth, or gastrointestinal disturbances. Yuvicyp-T Syrup offers a dual therapeutic approach, enhancing patient outcomes through combined antihistaminic and hepatoprotective mechanisms.